









Mercado
/
Acciones
/
nasdaq-ci
/

Cigna Group

278.090USD

+8.490+3.15%

Cierre 11/21, 16:00（ET）Cotizaciones retrasadas 15 min

74.14BCap. mercado

12.06P/E TTM



Cigna Group

278.090

+8.490+3.15%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Cigna Group Compañía

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.

Información de Cigna Group



Símbolo de cotizaciónCI

Nombre de la empresaCigna Group

Fecha de salida a bolsaApr 01, 1982

Director ejecutivoMr. David M. Cordani, CPA

Número de empleados73500

Tipo de seguridadOrdinary Share

Fin del año fiscalApr 01

Dirección900 Cottage Grove Road

CiudadBLOOMFIELD

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal06002

Teléfono18602266000

Sitio Webhttps://www.thecignagroup.com/

Símbolo de cotizaciónCI

Fecha de salida a bolsaApr 01, 1982

Director ejecutivoMr. David M. Cordani, CPA

Ejecutivos de Cigna Group



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

65.23K

+1.40%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+11.66%

Ms. Kathleen M. Mazzarella

Independent Director

6.11K

+11.66%

Ms. Kimberly A. Ross

Independent Director

4.51K

+16.47%

Mr. George Kurian

Independent Director

3.78K

+20.32%

Ms. Neesha Hathi

Independent Director

3.37K

+23.36%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David M. Cordani, CPA

Chairman of the Board, Chief Executive Officer

667.15K

-3.82%

Mr. Brian C. Evanko

President, Chief Operating Officer

65.23K

+1.40%

Ms. Donna F. Zarcone, CPA

Independent Director

26.73K

+2.44%

Mr. Eric C. Wiseman

Lead Independent Director

23.16K

+2.83%

Dr. Mark B. Mcclellan, M.D., Ph.D.

Independent Director

6.11K

+11.66%

Maj. Gen. (Retd.) Elder Granger, M.D.

Independent Director

6.11K

+11.66%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Pharmacy revenues

53.65B

79.86%

Premiums

9.16B

13.63%

Fees and other revenues

4.14B

6.16%

Other revenues

236.00M

0.35%

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Pharmacy revenues

53.65B

79.86%

Premiums

9.16B

13.63%

Fees and other revenues

4.14B

6.16%

Other revenues

236.00M

0.35%

Estadísticas de accionistas

Actualizado: lun., 17 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.73%

State Street Investment Management (US)

4.54%

T. Rowe Price Associates, Inc.

4.08%

MFS Investment Management

3.95%

Otro

73.11%

Accionistas

Proporción

The Vanguard Group, Inc.

9.59%

BlackRock Institutional Trust Company, N.A.

4.73%

State Street Investment Management (US)

4.54%

T. Rowe Price Associates, Inc.

4.08%

MFS Investment Management

3.95%

Otro

73.11%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

52.75%

Investment Advisor/Hedge Fund

28.33%

Research Firm

2.55%

Pension Fund

2.25%

Bank and Trust

1.71%

Hedge Fund

1.58%

Sovereign Wealth Fund

1.39%

Corporation

1.19%

Individual Investor

0.39%

Otro

7.85%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

2928

239.45M

89.63%

-7.76M

2025Q2

2945

245.93M

92.13%

-10.11M

2025Q1

2995

251.66M

94.16%

-8.16M

2024Q4

2993

255.45M

93.32%

-4.13M

2024Q3

2931

253.73M

90.72%

-10.03M

2024Q2

2910

254.99M

91.23%

-15.89M

2024Q1

2865

261.02M

89.38%

-14.30M

2023Q4

2815

267.28M

91.36%

-8.83M

2023Q3

2725

267.63M

91.08%

-13.20M

2023Q2

2737

270.13M

91.28%

-8.82M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

25.60M

9.59%

-429.07K

-1.65%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.41M

4.65%

-851.92K

-6.42%

Jun 30, 2025

State Street Investment Management (US)

12.26M

4.59%

-209.47K

-1.68%

Jun 30, 2025

T. Rowe Price Associates, Inc.

9.90M

3.71%

-1.75M

-15.05%

Jun 30, 2025

MFS Investment Management

11.41M

4.28%

+104.02K

+0.92%

Jun 30, 2025

Dodge & Cox

8.95M

3.35%

+60.88K

+0.68%

Jun 30, 2025

Fidelity Management & Research Company LLC

8.81M

3.3%

-1.72M

-16.31%

Jun 30, 2025

Sanders Capital, LLC

7.79M

2.92%

-196.42K

-2.46%

Jun 30, 2025

GQG Partners, LLC

5.77M

2.16%

+883.02K

+18.07%

Jun 30, 2025

Geode Capital Management, L.L.C.

5.96M

2.23%

-73.58K

-1.22%

Jun 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

iShares U.S. Healthcare Providers ETF

9.69%

VictoryShares Free Cash Flow ETF

3.94%

Invesco Dynamic Buyback Achievers ETF

3.8%

Monarch Dividend Plus Index ETF

3.25%

TrueShares Low Volatility Equity Income ETF

3.04%

iShares ESG Aware MSCI USA Value ETF

2.87%

Monarch Volume Factor Dividend Tree Index ETF

2.72%

VictoryShares US Multi-Factor Minimum Vol ETF

2.56%

Bushido Capital US Equity ETF

2.25%

Brandes US Value ETF

2.22%

iShares U.S. Healthcare Providers ETF

Proporción9.69%

VictoryShares Free Cash Flow ETF

Proporción3.94%

Invesco Dynamic Buyback Achievers ETF

Proporción3.8%

Monarch Dividend Plus Index ETF

Proporción3.25%

TrueShares Low Volatility Equity Income ETF

Proporción3.04%

iShares ESG Aware MSCI USA Value ETF

Proporción2.87%

Monarch Volume Factor Dividend Tree Index ETF

Proporción2.72%

VictoryShares US Multi-Factor Minimum Vol ETF

Proporción2.56%

Bushido Capital US Equity ETF

Proporción2.25%

Brandes US Value ETF

Proporción2.22%

Dividendos



Un total de 5.74B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Jan 30, 2025

CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option

Mar 05, 2025

Mar 20, 2025

Mar 05, 2025

Oct 23, 2024

CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024

Dec 04, 2024

Dec 19, 2024

Dec 04, 2024

Jul 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option

Sep 04, 2024

Sep 19, 2024

Sep 04, 2024

Apr 24, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option

Jun 04, 2024

Jun 20, 2024

Jun 04, 2024

Feb 02, 2024

CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option

Mar 06, 2024

Mar 21, 2024

Mar 05, 2024

Oct 25, 2023

CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option

Sep 06, 2023

Sep 21, 2023

Sep 05, 2023

Apr 26, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option

Jun 07, 2023

Jun 22, 2023

Jun 06, 2023

Feb 03, 2023

CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option

Mar 08, 2023

Mar 23, 2023

Mar 07, 2023

Oct 26, 2022

CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022

Dec 06, 2022

Dec 21, 2022

Dec 05, 2022

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Cigna Group?



Los cinco principales accionistas de Cigna Group son:
The Vanguard Group, Inc. posee 25.60M acciones, lo que representa el 9.59% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 12.41M acciones, lo que representa el 4.65% del total de acciones.
State Street Investment Management (US) posee 12.26M acciones, lo que representa el 4.59% del total de acciones.
T. Rowe Price Associates, Inc. posee 9.90M acciones, lo que representa el 3.71% del total de acciones.
MFS Investment Management posee 11.41M acciones, lo que representa el 4.28% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Cigna Group?



Los tres principales tipos de accionista de Cigna Group son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

¿Cuántas instituciones poseen acciones de Cigna Group (CI)?



A fecha de 2025Q3, 2928 instituciones poseen acciones de Cigna Group, con un valor de mercado combinado de aproximadamente 239.45M, lo que representa el 89.63% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -2.49%.

¿Cuál es la mayor fuente de ganancias de Cigna Group?



El FY2025Q2, el segmento empresarial Pharmacy revenues generó la ganancia más alta para Cigna Group, ascendiendo a 53.65B y representando el 79.86% de la ganancia total.

KeyAI

